According to new market research, the global smart drug delivery systems market reached $12 billion in 2024 and is expected ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU Medical" or "the Company") for ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

Medical device maker ICU Medical changed the designs of infusion pumps made in Minnesota without properly clearing important ...

The Law Offices of Frank R. Cruz announces an investigation of ICU Medical, Inc. ("ICU Medical" or the "Company") (NASDAQ: ICUI) on behalf of investors concerning the Company's possible violations of ...

The global healthcare industry continues to evolve at an extraordinary pace, driven by advancements in medical technology and the ever-growing demand for personalized treatment solutions. Among the ...

The infusion pumps market is experiencing significant growth due to the increasing demand for advanced healthcare solutions, particularly in the management of chronic diseases and critical care.

The Infusion Pump Market is valued at USD 14257.99 Million in 2022 and is expected to reach USD 27383.94 Million by 2030 at a ...

A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration.

India has introduced advanced Parkinson’s treatments like apomorphine injections and infusion pumps, while local researchers ...

Insulin solutions must be placed in an infusion pump and piggybacked into the lower distal port of a maintenance i.v. line with a rate of at least 20 mL/hr. (Use 0.9% sodium chloride injection if ...